The Experimental Irradiation core provides for the use of radiation by the members of the University of Michigan Comprehensive Cancer Center (UMCCC). The services of this core are critical to a variety of users in the UMCCC such as those Interested in radiation biology and radiation therapy, and those for whom radiation serves a research tool. Thus, it serves the goal of the Cancer Center to encourage basic research as well as translation and clinical applications. The irradiation core maintains and operates the irradiators and also consults with each investigator before initiation of a project, The experience and expertise of the director and manager allow them to offer Investigators Information on dosage and treatment regimens, particularly In animal studies, so that experimental resources are used In an optimal way. Another goal of the core is to foster Interactions between the users of the core by connecting investigators who have used radiation In various types of experiments over the last several years. Use of the Experimental Irradiation core by a variety of members of the Cancer Center is exemplified by the distribution of users. The 53 Cancer Center members who utilize the core participate In 10 Programs Including Breast Oncology, Cancer Cell Biology, Experimental Therapeutics, Gastrointestinal Oncology, and Radiation Sciences, among others. In order to provide this vital service, the core maintains 4 Irradiation devices. The 2 orthovoltage units (In the Medical Science I and Biomedical Science buildings) are used for irradiations of cell cultures and animals (primarily mice and rats but also available for use with rabbits and dogs). The core also maintains a small animal irradiator located In tine specific pathogen free area of the mouse housing in ULAM. The availability of this unit allows Investigators to perform Irradiations without removing immunodeficient mice from the quarantined facility. The fourth Irradiator Is for low dose rate (0.1-0.3 Gy/hour) irradiations. This irradiator, located within the Radiation Oncology department in the Medical Science I Building is built inside a humidified CO{2} Incubator, permitting studies of chronic exposure to very low radiation dose rates. The core is planning to expand Its services to also offer Cancer Center members the opportunity to Irradiate cell or DNA samples with ultraviolet light of different wavelengths.

Public Health Relevance

The Irradiation core maintains and operates the irradiators and also consults with each investigator before Initiation of a project. The experience and expertise of the director and manager allow them to offer investigators Information on dosage and treatment regimens, particularly In animal studies, so that experimental resources are used In an optimal way.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA046592-26
Application #
8696624
Study Section
Subcommittee B - Comprehensiveness (NCI)
Project Start
Project End
Budget Start
2014-06-01
Budget End
2015-05-31
Support Year
26
Fiscal Year
2014
Total Cost
Indirect Cost
Name
University of Michigan Ann Arbor
Department
Type
DUNS #
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Skolarus, Ted A; Metreger, Tabitha; Hwang, Soohyun et al. (2017) Optimizing veteran-centered prostate cancer survivorship care: study protocol for a randomized controlled trial. Trials 18:181
Hertz, Daniel L; Speth, Kelly A; Kidwell, Kelley M et al. (2017) Variable aromatase inhibitor plasma concentrations do not correlate with circulating estrogen concentrations in post-menopausal breast cancer patients. Breast Cancer Res Treat 165:659-668
Pinskey, Justine M; Franks, Nicole E; McMellen, Alexandra N et al. (2017) Neuropilin-1 promotes Hedgehog signaling through a novel cytoplasmic motif. J Biol Chem 292:15192-15204
Maj, Tomasz; Wang, Wei; Crespo, Joel et al. (2017) Oxidative stress controls regulatory T cell apoptosis and suppressor activity and PD-L1-blockade resistance in tumor. Nat Immunol 18:1332-1341
Zhang, Jie; Feng, Shumei; Su, Wenmei et al. (2017) Overexpression of FAM83H-AS1 indicates poor patient survival and knockdown impairs cell proliferation and invasion via MET/EGFR signaling in lung cancer. Sci Rep 7:42819
Mann, J E; Hoesli, R; Michmerhuizen, N L et al. (2017) Surveilling the Potential for Precision Medicine-driven PD-1/PD-L1-targeted Therapy in HNSCC. J Cancer 8:332-344
Birkeland, Andrew C; Foltin, Susan K; Michmerhuizen, Nicole L et al. (2017) Correlation of Crtc1/3-Maml2 fusion status, grade and survival in mucoepidermoid carcinoma. Oral Oncol 68:5-8
Walline, Heather M; Goudsmit, Christine M; McHugh, Jonathan B et al. (2017) Integration of high-risk human papillomavirus into cellular cancer-related genes in head and neck cancer cell lines. Head Neck 39:840-852
Walline, Heather M; Carey, Thomas E; Goudsmit, Christine M et al. (2017) High-Risk HPV, Biomarkers, and Outcome in Matched Cohorts of Head and Neck Cancer Patients Positive and Negative for HIV. Mol Cancer Res 15:179-188
Chen, Yan; Zhou, Quan; Li, Xue et al. (2017) Ultrasmall Paramagnetic Iron Oxide Nanoprobe Targeting Epidermal Growth Factor Receptor for In Vivo Magnetic Resonance Imaging of Hepatocellular Carcinoma. Bioconjug Chem 28:2794-2803

Showing the most recent 10 out of 1355 publications